Dr. Benjamin A. Raby, MD

Dr. Raby practices at Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital.

Dr. Raby's NPI, 1245299544, was assigned on March 23, 2006. Dr. Raby holds Massachusetts license 209964.

Dr. Raby's primary practice is Boston Children's Hospital, at 300 Longwood Avenue, Boston, MA 02115 in Suffolk County. The practice phone is (617) 735-6000.

Dr. Raby's primary practice is Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital. Dr. Raby is also affiliated with Brigham and Women's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Raby to 1 more dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raby practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Raby's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Raby is licensed in Massachusetts.

CMS data shows 206 Medicare services from Dr. Raby across 6 procedure codes in 2018, for 15 Medicare patients. Medicare paid $15,177 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Dr. Raby in 2024. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raby's median patient age at 49, with 53% women.

In 2024, Dr. Raby wrote 33 Medicare Part D claims. 55% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $9,424 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Raby accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raby as offering telehealth.

Dmand AI links 123 papers to Dr. Raby, published from 2012 to 2025. 2020 was the busiest year, with 14. The most frequent topics are Asthma, Lung and Genetic Predisposition to Disease. Dr. Raby has published most often in Am J Respir Crit Care Med. Dr. Raby's most frequent co-authors are Scott T. Weiss, MD, Esteban G. Burchard, MD and Ivan Orlando Rosas, MD.

CMS Open Payments shows 13 general payments to Dr. Raby from 3 drug and device companies from 2017 to 2018. Consulting fees make up the largest share, 93% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $13,652.